These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10225969)

  • 1. New protective antigen of group A streptococci.
    Dale JB; Chiang EY; Liu S; Courtney HS; Hasty DL
    J Clin Invest; 1999 May; 103(9):1261-8. PubMed ID: 10225969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spa contributes to the virulence of type 18 group A streptococci.
    McLellan DG; Chiang EY; Courtney HS; Hasty DL; Wei SC; Hu MC; Walls MA; Bloom JJ; Dale JB
    Infect Immun; 2001 May; 69(5):2943-9. PubMed ID: 11292710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tetravalent group A streptococcal M protein vaccine.
    Dale JB; Chiang EY; Lederer JW
    J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci.
    Ahmed EA; Penfound TA; Brewer SC; Tennant PA; Chiang EY; Dale JB
    Eur J Clin Microbiol Infect Dis; 2010 Jan; 29(1):51-7. PubMed ID: 19865839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein.
    Dale JB; Beachey EH
    J Exp Med; 1986 May; 163(5):1191-202. PubMed ID: 2422314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group A streptococcus expresses a trio of surface proteins containing protective epitopes.
    Niedermeyer SE; Penfound TA; Hohn C; Li Y; Homayouni R; Zhao J; Dale JB
    Clin Vaccine Immunol; 2014 Oct; 21(10):1421-5. PubMed ID: 25080552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses.
    Bronze MS; Courtney HS; Dale JB
    J Immunol; 1992 Feb; 148(3):888-93. PubMed ID: 1370521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
    Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
    J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning and sequence analysis of a gene encoding a 67-kilodalton myosin-cross-reactive antigen of Streptococcus pyogenes reveals its similarity with class II major histocompatibility antigens.
    Kil KS; Cunningham MW; Barnett LA
    Infect Immun; 1994 Jun; 62(6):2440-9. PubMed ID: 8188369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.
    Bessen D; Fischetti VA
    J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of group B protective surface protein, a new cell surface protective antigen of group B streptococci.
    Erdogan S; Fagan PK; Talay SR; Rohde M; Ferrieri P; Flores AE; Guzmán CA; Walker MJ; Chhatwal GS
    Infect Immun; 2002 Feb; 70(2):803-11. PubMed ID: 11796614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping a conserved conformational epitope from the M protein of group A streptococci.
    Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
    Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum opacity factor (SOF) of Streptococcus pyogenes evokes antibodies that opsonize homologous and heterologous SOF-positive serotypes of group A streptococci.
    Courtney HS; Hasty DL; Dale JB
    Infect Immun; 2003 Sep; 71(9):5097-103. PubMed ID: 12933852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein.
    Beachey EH; Seyer JM
    J Immunol; 1986 Mar; 136(6):2287-92. PubMed ID: 2419429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective immunogenicity of group A streptococcal M-related proteins.
    Dale JB; Niedermeyer SE; Agbaosi T; Hysmith ND; Penfound TA; Hohn CM; Pullen M; Bright MI; Murrell DS; Shenep LE; Courtney HS
    Clin Vaccine Immunol; 2015 Mar; 22(3):344-50. PubMed ID: 25630406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vimentin-cross-reactive epitope of type 12 streptococcal M protein.
    Kraus W; Seyer JM; Beachey EH
    Infect Immun; 1989 Aug; 57(8):2457-61. PubMed ID: 2473037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immune response to immunization with a structurally defined polypeptide fragment of streptococcal M protein.
    Beachey EH; Stollerman GH; Johnson RH; Ofek I; Bisno AL
    J Exp Med; 1979 Oct; 150(4):862-77. PubMed ID: 390084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
    BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group A streptococcal M proteins: virulence factors and protective antigens.
    Robinson JH; Kehoe MA
    Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats.
    Vohra H; Dey N; Gupta S; Sharma AK; Kumar R; McMillan D; Good MF
    Res Microbiol; 2005 May; 156(4):575-82. PubMed ID: 15862457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.